Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06678633Not ApplicableNot Yet Recruiting

T-Control® Safety for Cytostatics Management

Role: lead

NCT06474845Not ApplicableSuspended

Efficacy of the T-Control® Catheter Compared to the Foley-type Catheter in Patients With Long-term Catheterization

Role: lead

NCT05860231Not ApplicableSuspended

Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization

Role: lead

NCT05643950Not ApplicableWithdrawn

Effectiveness and Cost-effectiveness of the T-Control® Catheter in Patients With Acute Urine Retention

Role: lead

All 4 trials loaded